Peter Mandelson's lobbying firm hired by company linked to Chinese military amid US biosecurity bill controversy
Global Counsel, the lobbying firm co-founded by former UK deputy prime minister Peter Mandelson, has been hired by WuXi AppTec, a Chinese pharmaceutical company accused of ties to China's military. The move comes as US lawmakers have proposed a biosecurity bill aimed at preventing "adversary biotech companies" from obtaining federal government funding.
WuXi AppTec signed a $3 million contract with Global Counsel last year to deal with the international fallout from claims it had links with the Chinese military and was implicated in human rights abuses in Xinjiang. The company is under scrutiny over its alleged ties to China's military, with some US lawmakers calling for an investigation into its connections.
Global Counsel offered to help WuXi AppTec on "geopolitical risk mitigation" in May 2024, soon after the company was singled out in a draft bill as having ties to "a foreign adversary's military, internal security forces, or intelligence agencies". The lobbying firm said it only worked with WuXi AppTec on European policy issues, not US ones, and had declared this on the EU's transparency register.
The move has raised concerns about Mandelson's ties to China and his suitability for his current role as UK ambassador to Washington. Critics of Beijing have accused him of being too friendly towards China, while his appointment was criticized by some over his past friendship with Jeffrey Epstein.
WuXi AppTec is one of several Chinese companies that have appeared on Global Counsel's client roster in recent years, including TikTok and Shein. The company has denied the allegations against it, but its US and European president, Richard Connell, has raised concerns about the biosecurity bill's impact on biotechnology innovation.
A new version of the bill was endorsed by the US Senate last month, which adopted a softer tone and omitted any mention of WuXi companies. Earlier this month, WuXi AppTec announced plans to set up its first European headquarters in Germany.
Global Counsel, the lobbying firm co-founded by former UK deputy prime minister Peter Mandelson, has been hired by WuXi AppTec, a Chinese pharmaceutical company accused of ties to China's military. The move comes as US lawmakers have proposed a biosecurity bill aimed at preventing "adversary biotech companies" from obtaining federal government funding.
WuXi AppTec signed a $3 million contract with Global Counsel last year to deal with the international fallout from claims it had links with the Chinese military and was implicated in human rights abuses in Xinjiang. The company is under scrutiny over its alleged ties to China's military, with some US lawmakers calling for an investigation into its connections.
Global Counsel offered to help WuXi AppTec on "geopolitical risk mitigation" in May 2024, soon after the company was singled out in a draft bill as having ties to "a foreign adversary's military, internal security forces, or intelligence agencies". The lobbying firm said it only worked with WuXi AppTec on European policy issues, not US ones, and had declared this on the EU's transparency register.
The move has raised concerns about Mandelson's ties to China and his suitability for his current role as UK ambassador to Washington. Critics of Beijing have accused him of being too friendly towards China, while his appointment was criticized by some over his past friendship with Jeffrey Epstein.
WuXi AppTec is one of several Chinese companies that have appeared on Global Counsel's client roster in recent years, including TikTok and Shein. The company has denied the allegations against it, but its US and European president, Richard Connell, has raised concerns about the biosecurity bill's impact on biotechnology innovation.
A new version of the bill was endorsed by the US Senate last month, which adopted a softer tone and omitted any mention of WuXi companies. Earlier this month, WuXi AppTec announced plans to set up its first European headquarters in Germany.